Rates of central nervous system progression in non-small cell lung cancer patients treated with EGFR-TKI's vs. chemotherapy

8059 Background: Case reports have shown that EGFR-TKI’s can be effective against brain mets from NSCLC. It is unclear, however, what effect these agents might have on the rate and time to occurren...